about
Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score.2012 pandemic fluSuccessful use of bivalirudin for cardiopulmonary bypass in a patient with heparin allergy.Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated.Treatment of heparin-induced thrombocytopenia after cardiac surgery: preliminary experience with fondaparinux.Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.A new phosphorylcholine-coated polymethylpentene oxygenator for extracorporeal membrane oxygenation: a preliminary experience.Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices.Anticoagulation for critically ill cardiac surgery patients: is primary bivalirudin the next step?Do we need heparin coating for extracorporeal membrane oxygenation? New concepts and controversial positions about coating surfaces of extracorporeal circuits.Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMOBeating-heart coronary artery bypass graft surgery at San Raffaele Hospital: four years of experience.Preoperative intra-aortic balloon pump to reduce mortality in coronary artery bypass graft: a meta-analysis of randomized controlled trials.The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience.Different anesthesiological management in two high risk pregnant women with heart failure undergoing emergency cesarean section.Percutaneous tracheostomy in patients on anticoagulants.Aspirin has limited ability to modulate shear-mediated platelet activation associated with elevated shear stress of ventricular assist devices.Is there light at the end of the tunnel?-new perspectives in ECMO survival.Cesarean section in a patient with non-compaction cardiomyopathy managed with ECMOCardiac valve involvement in systemic diseases: a review.The pivotal role of echocardiography in the assessment of multivalvular heart disease.Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial.Management of refractory hypoxemia during venovenous extracorporeal membrane oxygenation for ARDS.High Frequency Components of Hemodynamic Shear Stress Profiles are a Major Determinant of Shear-Mediated Platelet Activation in Therapeutic Blood Recirculating Devices.Modalities and Effects of Left Ventricle Unloading on Extracorporeal Life support: a Review of the Current Literature.Mitral Valve Repair Without Repair of Moderate Tricuspid Regurgitation.Extracorporeal CO2 removal in critically ill patients: a systematic review.Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock.Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study.Long-term results of mitral repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: does the technique matter?Greater temperature variability is not associated with a worse neurological outcome after cardiac arrest.Shear-mediated platelet activation in patients implanted with continuous flow LVADs: A preliminary study utilizing the platelet activity state (PAS) assay.Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience.Treating Life-Threatening Myocarditis by Blocking Interleukin-1.MitraClip therapy and surgical edge-to-edge repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: mid-term results of a single-centre experience†.An unusual cause of cardiogenic shock: tricuspid regurgitation and right ventricular perforation due to vena cava filter migration.Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repair.Spectroscopic and morphological characterization of inflow cannulas of left ventricular assist devices.What is extracorporeal cardiopulmonary resuscitation?Intra-aortic balloon pump during venoarterial extracorporeal membrane oxygenation: still a matter of debate? Contemporary multi-device approach to cardiogenic shock.
P50
Q30423740-A8F94442-7CDA-4F90-9699-7DFC70D80560Q30427600-0CED9AD8-1532-450B-B22B-862C653EBEC4Q33375899-96F12D47-E02E-4FA2-A4B5-21938EF7AA5CQ33385656-5B237801-66E7-403A-9A13-07E0632B0309Q33385696-DFC92889-1144-4D8C-94DF-6A6C8E487E10Q33403661-CAF6C13D-0614-4D6F-BAE8-9149DAEF2D88Q33404637-B3FA5321-171C-43E6-AC61-54F7A82571EFQ33410802-56425128-8F8A-461B-B083-3FEBD5BFE735Q33412797-B7568373-B850-4111-B7EA-9CBA767459D5Q33416578-8F6B34AF-B720-4A3E-B25F-F255831976CEQ33752972-D51DBAC3-521F-4740-8B17-16100BA0BADEQ35027412-0B71A242-C9CA-4A77-B608-4CE3592D0FB0Q35542843-E849E620-8719-4C55-B64E-3B161E7FE8CCQ35807196-B52DB835-7ADA-4BF4-9DF3-4FC1435EF9A7Q36100046-4CEE86AA-362C-4BBB-86FA-108E3CF75E0DQ36939582-CC91CF3B-8CDA-4D03-847F-F7490D58E41BQ37046266-B578E385-3626-4678-BC58-203F3B08EC86Q37208712-2EC9C802-20EC-4F87-B250-887EA001222BQ37359688-245C1369-D6DD-46AF-9515-861BDBBD5288Q38081405-EB0877C4-1C2C-44A4-9E91-460155B8A86AQ38089465-9EB986CC-E195-45B6-9FDF-4F145E15A014Q38423069-CACFEECB-9A36-48B6-AC3B-3D042320DAA5Q38449007-B68C1BC8-6226-4E54-987B-C091DEE9E146Q38685333-124F6F26-6F6E-4ABE-94BC-6AECF05EBC69Q38805377-DD3C2877-CD92-44AE-8B1D-4BA5A581D51BQ38968368-FD8435BD-BB0F-49A9-9826-B71B14106E28Q39237357-B51886F1-B379-441E-819E-AE4919A6ADCBQ39317396-0B42D071-75F1-4EB9-8C5D-B92333C245D7Q39654953-AA1FDD15-F8CA-4ED0-B3DB-8E21902FF51FQ39812437-FCC6426A-5E1D-4B1F-ACB6-2149280805EEQ40138544-BD5B71A5-FDA5-49DA-BCBF-2BFBC9A646F6Q40139205-5CC63DD3-8214-4CF8-89A8-26FB9268FEE1Q40374068-01C9062B-62BC-40DC-96E1-57B9A8C922E7Q40825137-936E9215-3335-415D-986F-3244ABFF7261Q41452667-0D66E85A-6645-4F8D-80EF-2A49C4E0B484Q41613077-8E90F59D-631E-4598-BB41-21D3DE54A301Q41622177-D671366A-3E85-4C25-9E8B-016C92724A58Q41662152-5CADCAD7-7F87-43A1-98FC-569BF07F2B46Q42332758-4B47CD9D-A6E7-4E3A-BADF-17425801BFC6Q42340588-B83A0D62-A717-4BFC-8468-B03DEDE964E2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Federico Pappalardo
@ast
Federico Pappalardo
@en
Federico Pappalardo
@es
Federico Pappalardo
@nl
Federico Pappalardo
@sl
type
label
Federico Pappalardo
@ast
Federico Pappalardo
@en
Federico Pappalardo
@es
Federico Pappalardo
@nl
Federico Pappalardo
@sl
prefLabel
Federico Pappalardo
@ast
Federico Pappalardo
@en
Federico Pappalardo
@es
Federico Pappalardo
@nl
Federico Pappalardo
@sl
P106
P21
P31
P496
0000-0001-9129-833X